Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 DKK | -0.57% | -2.78% | -16.27% |
May. 08 | BioPorto A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Bioporto A/S Provides Earnings Guidance for 2024 | CI |
Sales 2024 * | 40M 5.81M | Sales 2025 * | - | Capitalization | 664M 96.58M |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.52M | Net income 2025 * | - | EV / Sales 2024 * | 16.6 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-17.5
x | P/E ratio 2025 * |
-
| Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | -0.57% | ||
1 week | -2.78% | ||
Current month | +35.03% | ||
1 month | +42.51% | ||
3 months | +2.94% | ||
6 months | -28.43% | ||
Current year | -16.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1.75 | -0.57% | 503,669 |
24-05-23 | 1.76 | +1.03% | 640,078 |
24-05-22 | 1.742 | -2.02% | 448,558 |
24-05-21 | 1.778 | -1.22% | 290,417 |
24-05-17 | 1.8 | -2.49% | 526,501 |
Delayed Quote Nasdaq Copenhagen, May 24, 2024 at 10:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.27% | 96.93M | |
-4.92% | 12.11B | |
-5.82% | 8.07B | |
+5.43% | 5.67B | |
+26.16% | 5.48B | |
-9.58% | 4.12B | |
-59.63% | 2.75B | |
+8.44% | 2.62B | |
-3.70% | 2.33B | |
+21.00% | 2.11B |
- Stock Market
- Equities
- BIOPOR Stock